Photo taken from Manni Mohyuddin/X
Jan 5, 2024, 22:42
Manni Mohyuddin: How I treat new myeloma
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, shared on X/Twitter:
“How I treat new myeloma:
– Fit/stnd-risk/wants transplant: DRVd > Auto > Len maint
– Fit/stnd-risk/transplant: DRVd (6-8c) > Len (or dara+len)
– Fit/high-risk: DRVD > Auto > Len or Len+K if accepts opportunity cost for small benefit
– Neuropathy: Use K (not V)
– Older/non-fit: DRd
Caveats:
– Standard risk/MRD neg after auto: Still recommend len maint- although I believe benefit small/needs tested in RCT
– Quads in those I didn’t transplant: Do not have good data to guide on how to de-escalate
– Only 1 high-risk cytogenetic: Usually NO doublet maintenance”
Source: Manni Mohyuddin/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 20, 2024, 12:34
Nov 20, 2024, 11:34
Nov 20, 2024, 11:23
Nov 20, 2024, 10:18